The landscape of neuropsychiatric care has reached a significant milestone following the United States Food and Drug Administration (FDA) approval…
Read More
Roche Secures FDA Approval for Tecentriq in Stage III dMMR Colon Cancer Setting to Establish New Treatment Paradigm
The pharmaceutical landscape for gastrointestinal oncology has undergone a significant transformation following a landmark regulatory decision by the US Food…
Read More
FDA Expands Approval of Bristol Myers Squibb’s Camzyos to Treat Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
The United States Food and Drug Administration (FDA) has officially expanded the approved indication for Bristol Myers Squibb’s (BMS) flagship…
Read More
FDA Approval of Tavapadon (Juvmo) Validates AbbVie’s $8.7bn Cerevel Takeover and Ushers in a New Era for Parkinson’s Treatment
The United States Food and Drug Administration has officially approved tavapadon, a next-generation dopamine-based therapy developed for the management of…
Read More
Scholar Rock Secures Landmark FDA Approval for Isemblyd, Ushering in a New Era of Muscle-Targeted Spinal Muscular Atrophy Treatments
The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More
Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
GSK Secures US Approval for Jideytro in ROS1-Positive Lung Cancer, Entering Competitive Market
Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…
Read More
Novo Nordisk Secures European Approval for Oral Wegovy, Bolstering First-Mover Advantage in Obesity Pill Market
Novo Nordisk has solidified its pioneering position in the burgeoning market for oral obesity medications with the European Commission’s marketing…
Read More
MSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic Diversification
The pharmaceutical landscape has been significantly reshaped with MSD (Merck & Co.) achieving a monumental victory: the US Food and…
Read More
Novartis Fabhalta Receives Traditional FDA Approval for IgAN Treatment
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Novartis for Fabhalta (iptacopan), a groundbreaking oral Factor…
Read More
